Figures & data
Table 1. The characteristic of study population between completed follow-up and not complete follow-up.
Table 2. Percentage of subjects with anti-HBs titers 0–9, 10–99, 100–999 and ≥1000 mIU/mL and GMC at twelve years after the primary series, stratified by immunization schedule.
Table 3. Multivariable model analysis on seroprotection rate (≥10 mIU/ml) and GMC at twelve years after HepB-SC primary immunization.